United States · Wires & real time · PR Newswire

Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment

Published by PR Newswire · United States 1 h ago

Earns ESG Risk Rating score of 9.0, ranking among the top 0.5% in the pharmaceuticals industry Advances from 'Low Risk' to 'Negligible Risk,' the lowest ESG risk category…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

MT Newswires

Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment

Share

Also worth reading

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot